Christian Jones

Christian Jones

BakerHostetler

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › Medicare Part D

Share:

Capitol Hill Healthcare Update

PELOSI INTRODUCES DRUG PRICING BILL WHILE TRUMP PUSHES SENATE VERSION - House Democrats introduced legislation last week to lower prescription drug prices – including allowing Medicare to negotiate prices with...more

9/23/2019  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

UPDATE ON DRUG PRICING LEGISLATION AS CONGRESS RECONVENES - Congress reconvenes this week after a monthlong summer recess and begins what likely will be a final push toward overhauling prescription drug prices, but lack of...more

9/10/2019  /  Drug Pricing , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more

7/15/2019  /  Cadillac Tax , Drug Pricing , Generic Drugs , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Surprise Medical Bills , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. McCONNELL WANTS BIPARTISAN DEAL ON DRUG PRICES BY JULY - To schedule time for debate in the Senate on...more

6/24/2019  /  Drug Pricing , Medical Devices , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Surprise Medical Bills

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session....more

6/11/2019  /  Data Breach , Data Protection , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare for All , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Prior Authorization

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. DRUG PRICES: CONGRESS RETURNS, PICKS UP WHERE LAWMAKERS LEFT OFF - Congress reconvenes today after a...more

4/29/2019  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare for All , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Azar testifies before three committees on HHS’ budget; a series of Senate bills targeting...more

3/11/2019  /  Biologics , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices;...more

3/4/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Finger-pointing But Few Fireworks at Senate Hearing on Drug Prices

Amid finger-pointing but few real fireworks, the seven pharmaceutical executives testifying before the Senate Finance Committee today offered lawmakers a spirited defense of the industry but also substantive policy...more

2/27/2019  /  Drug Pricing , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Pharma industry CEOs testify before a Senate committee; House and Senate panels probe...more

2/26/2019  /  Centers for Medicare & Medicaid Services (CMS) , Cybersecurity , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: shutdown risk increases as talks stall; Gottlieb’s Hill testimony postponed; more bills...more

2/12/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part D , Opioid , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more

2/5/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medical Devices , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Preexisting Conditions , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: With the shutdown over (for now), the FDA is back in business; two hearings spotlight drug...more

1/29/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicaid , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Highlights this week: Gottlieb warns FDA’s funds running low as shutdown continues; House Dems launch sweeping probe on drug prices, Senate approves Medicaid measures, and more....more

1/23/2019  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicaid , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more....more

1/14/2019  /  Affordable Care Act , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Government Shutdown , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Tax Deductions

Capitol Hill Healthcare Update

Highlights this week include a lame duck update on year-end health bills and tax provisions; lawmakers reacting to a federal judge ruling the Affordable Care Act is unconstitutional; Sen. Hatch seeks to update Hatch-Waxman;...more

12/17/2018  /  Affordable Care Act , Congressional Budget Office , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Furloughs , Government Shutdown , Medicare Part D , Patents , Pharmaceutical Industry , Trump Administration , USPTO

Capitol Hill Healthcare Update

Highlights this week: Healthcare legislative priorities are caught up in a separate spending debate that could lead to a partial government shutdown; some GOP lawmakers push back on Trump’s Part B pilot program; a key...more

12/4/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

Highlights this week: Democrats’ takeover of the House will yield big changes for healthcare policy in 2019; several GOP lawmakers active in healthcare policy are defeated; pharma pushes for Part D changes in the lame duck;...more

11/13/2018  /  Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Lame Duck Session , Medical Devices , Medicare , Medicare Part A , Medicare Part D , Pharmaceutical Industry , Prescription Drug Coverage

Capitol Hill Healthcare Update

Included this week is an update on congressional efforts to finish opioids response legislation; efforts by pharmaceutical manufacturers to change discounts they are required to provide Medicare beneficiaries in the Part D...more

9/25/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

Featured in this week’s Update, the Senate votes on September 17, 2018 on opioids legislation (the House is not in session this week); Congress reaches an agreement on fiscal 2019 healthcare funding; the pharma industry last...more

9/18/2018  /  Department of Health and Human Services (HHS) , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Pharmacies , Prescription Drugs , Trump Administration

Capitol Hill Healthcare Update

This week’s “Capitol Hill Healthcare Update” includes the latest on a pending Senate vote on opioid legislation as Congress races to enact a response to the crisis before the November election; the Senate votes to expand...more

9/11/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Disclosure Requirements , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Medicare Part D , Opioid , Pharmaceutical Industry , Prescription Drugs

Capitol Hill Healthcare Update

CONGRESS WORKS TO PASS BUDGET BEFORE FRIDAY’S SHUTDOWN DEADLINE - House leaders are pushing to schedule a vote this week on a $1.3 trillion budget agreement that would give the Senate enough time to pass it before a Friday...more

3/20/2018  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicaid , Medicare , Medicare Part D , Opioid , Prescription Drugs , Right to Try , Section 340B

Capitol Hill Healthcare Update

HOUSE VOTE SET FOR UPDATED ‘RIGHT-TO-TRY’ LEGISLATION - The House will vote Tuesday on updated but still controversial legislation that would give terminally ill patients wider access to prescription drugs that haven’t won...more

3/13/2018  /  Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , Patient Access , Pharmaceutical Industry , Prescription Drugs , Right to Try , Section 340B

Capitol Hill Healthcare Update

CONGRESS SCRAMBLES TO COMPLETE BUDGET IN ADVANCE OF DEADLINE - Lawmakers are working overtime – including on key healthcare issues – to wrap up work on a $1.2 trillion omnibus budget bill that would fund the government for...more

3/6/2018  /  Drug Pricing , Medicare , Medicare Part B , Medicare Part D , Opioid , Section 340B

Capitol Hill Healthcare Update

Congress is expected this week to approve a fifth stopgap budget bill to keep the government open in advance of a Thursday shutdown deadline, and key healthcare provisions could be included in the budget package. If...more

2/6/2018  /  Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part D , Opioid , REMS , Trump Administration
29 Results
 / 
View per page
Page: of 2
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide